Establishing an immortalized human osteoprecursor cell line: OPC1

Journal of Bone and Mineral Research

Volumn 14, Issue 10, 1999, Pages 1721-1733

  Winn, Shelley R ^a   Randolph, Gannon ^a   Uludag, Hasan ^b   Wong, Shou C ^c   Hair, Gregory A ^d   Hollinger, Jeffrey O ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Modex Therapeutics SA   (France)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; MESSENGER RNA; NEOMYCIN; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; PARATHYROID HORMONE RECEPTOR; PROCOLLAGEN;

ANTIGEN EXPRESSION; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL INTERACTION; ENZYME ACTIVITY; FETUS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OSTEOBLAST; STEM CELL;

ALKALINE PHOSPHATASE; CELL DIVISION; CELL SURVIVAL; EMBRYONIC AND FETAL DEVELOPMENT; FEASIBILITY STUDIES; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOENZYME TECHNIQUES; OSTEOBLASTS; OSTEOCALCIN; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 0032857101     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.10.1721     Document Type: Article

References (42)

1. Winn SR, Uludag H, Hollinger JO 1998 Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Del Rev 31:303-318.
2. Hollinger JO, Buck DC, Bruder S 1999 Biology of bone healing: Its impact on clinical therapy. In: Lynch SE, Genco RJ, Marx RE (eds.) Tissue Engineering: Applications in Maxillo-facial Surgery and Periodontics. Quintessence, San Diego, CA, U.S.A., pp. 17-53.
3. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA 1992 The healing of segmental bone defects induced by recombinant human bone morphogenetic protein (rhBMP-2). J Bone Joint Surg Am 74:659-671.
4. Smith JL, Jin L, Parsons T, Turek T, Ron E, Philbrook CM, Kenley RA, Marden L, Hollinger JO, Bostrom MPG, Tomin E, Lane JM 1995 Osseous regeneration in preclinical models using bioabsorbable delivery technology for recombinant human bone morphogenetic protein-2 (rhBMP-2). J Controlled Rel 36:183-195.
5. Hollinger JO, Mayer M, Buck D, Zegzula HD, Ron E, Smith J, Lin L, Wozney JM 1996 Poly (alpha-hydroxy acid) carrier for delivering recombinant human bone morphogenetic protein-2 for bone regeneration. J Controlled Rel 39:287-304.
6. Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Alder M, Nummikoski P 1997 A feasibility study evaluation rhBMP-2/absorbable collagen sponge for maxillary sinus augmentation. Int J Periodont Restor Dent 17:11-25.
7. Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M, Lilly L, Cochran D 1997 A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation of augmentation. Int J Periodont Restor Dent 17:125-139.
8. Vacanti CA, Kim WS, Upton J, Vacanti MP, Mooney D, Schloo B, Vacanti JP 1993 Tissue engineered growth of bone and cartilage. Trans Proc 25:1019-1021.
9. Vacanti CA, Vacanti JP 1997 Bone and cartilage reconstruction. In: R. Lanza R. Langer W. Chick (eds.) Principles of Tissue Engineering. RG Landes Co., Austin, TX, U.S.A., pp. 619-631.
10. Sudo H, Kodama H-A, Amagai Y, Yamamoto S, Kasai S 1983 In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96:191-198.
11. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA, Tanaka H, Omura S, Suda T 1990 The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 172:295-299.
12. Rodan SB, Imai Y, Thiede MA, Wesolowski G, Thompson D, Bar-Shavit Z, Shull S, Mann K, Rodan GA 1987 Characterization of a human cell line (Saos-2) with osteoblastic properties. Cancer Res 47:4961-4966.
13. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S 1991 Recombinant human bone morphogenetic protein-2 stiumulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113:681-687.
14. Thies RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM, Rosen V 1992 Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130:1318-1324.
15. Keeting PE, Scott RE, Colvard DS, Anderson MA, Oursler MJ, Spelsberg TC, Riggs BL 1992 Development and characterization of a rapidly proliferating, well-differentiated cell line derived from normal adult human osteoblast-like cells transfected with SV40 large T antigen. J Bone Miner Res 7:127-132.
16. Rosen V, Nove J, Song JJ, Theis RS, Cox K, Wozney JM 1994 Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. J Bone Miner Res 9:1759-1768.
17. Harris SA, Enger RJ, Riggs BL, Spelsberg TC 1995 Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10:178-186.
18. Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Katagiri T, Wozney JM, Rosen V, Yoshiki S 1996 Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 220:366-371.
19. Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL 1996 Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res 11:312-324.
20. Majors AK, Boehm CA, Nitto H, Midura RJ, Muschler GF 1997 Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res 15:546-557.
21. Fanning E, Knippers R 1992 Structure and function of simian virus 40T antigen. Annu Rev Biochem 61:55-85.
22. Manfredi JJ, Prives C 1994 Transforming activity of simian virus 40 large tumor antigen. Biochem Biophys Acta 1198:65-83.
23. Evans CE, Ng K, Allen J, Gallimore P 1995 Modulation of cell phenotype in human osteoblast-like cells by the simian virus 40. J Orthoped Res 13:317-324.
24. Kriegler M 1990 A laboratory manual. In: Kriegler M (ed.) Gene Transfer and Expression. Stockton Press, New York, NY, U.S.A., pp. 103-112.
25. Hammang JP, Greco CR, Kisseberth WC, Garbern JY, Messing A 1995 Glial cell lines derived from Mx-1-T-antigen transgenic mice exhibit inducible oncogene expression. Soc Neurosci Abs 21:1075.
26. Israel DI, Nove J, Kerns KM, Moutsatsis IK, Kaufman RJ 1992 Expression and characterization of bone morphogenetic proteins-2 in chinese hamster ovary cells. Growth Factors 7:139-150.
27. Gallagher JA, Gendle R, Beresford JN 1996 Isolation and culture of bone forming cells (osteoblasts) from human bone. In: Jones EH (ed.) Human Cell Culture Protocols. Humana Press, Totowa, NJ, U.S.A., pp. 233-262.
28. Bruder SP, Jaiswal N, Haynesworth SE 1997 Growth kinetics, self-renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64:278-294.
29. Lowry OH, Roberts NR, Wu M-L, Hixson WS, Crawford EJ 1954 The quantitative histochemistry of brain: Enzyme measurements. J Biol Chem 207:19-37.
30. Bilbe G, Roberts E, Birch M, Evans DB 1996 PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines. Bone 19:437-445.
31. Schinstine M, Fiore DM, Winn SR, Emerich DF 1995 Polymerencapsulated schwannoma cells expressing human nerve growth factor promote the survival of cholinergic neurons after fimbria-fornix transection. Cell Trans 4:93-102.
32. Steiner AL, Pagliara AS, Chase LR, Kipnis D 1972 Radioimmunoassay for cyclic nucleotides. II. Adenosine 3′,5′-monophosphate in mammalinan tissues and body fluids. J Biol Chem 247:1114-1120.
33. Rouleau M, Mitchell J, Goltzman D 1988 In vivo distribution of parathyroid hormone receptors in bone: Evidence that a predominant osseous target cell is not the mature osteoblast. Endocrinology 123:187-191.
34. Takeshita S, Kikuno R, Tezuka K, Amann E 1993 Osteoblast-specific factor 2: Cloning of a putative bone adhesion protein with homology with the insect protein fasciclin 1. Biochem J 294:271-278.
35. Kato Y, Windle JJ, Koop BA, Mundy GR, Bonewald LF 1997 Establishment of an osteocyte-like cell line, MLO-Y4. J Bone Miner Res 12:2014-2023.
36. Vukicevic S, Paralkar VM, Reddi AH 1993 Extracellular matrix and bone morphogenetic proteins in cartilage and bone development and repair. Adv Mol Cell Biol 6:207-224.
37. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whittiers MJ, Kriz RW, Hewick RM, Wang EA 1988 Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534.
38. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fijisawa-Sehara A, Suda T 1994 Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755-1766.
39. Kim KJ, Itoh T, Kotake S 1997 Effects of recombinant human bone morphogenetic protein-2 on human bone marrow cells cultured with various biomaterials. J Biomed Mater Res 35:279-285.
40. Takuwa Y, Ohse C, Wang EA, Wozney JM, Yamashita K 1991 Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochim Biophys Res Commun 174:96-101.
41. Puleo DA, Holleran LA, Doremus RH, Bizios R 1989 Osteoblast responses to orthopaedic implant materials in vitro. J Biomed Mater Res 25:711-723.
42. Hott M, Noel B, Bernache-Assolant D, Rey C, Marie PJ 1997 Proliferation and differentiation of human trabecular osteoblastic cell on hydroxyapatite. J Biomed Mater Res 37:508-516.